Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Bewersdorf JP 

PROVIDER: S-EPMC8238245 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature